ASX Share rice
Wed 05 Aug 2020 - 12:38:am (Sydney)

AC8 Share Price

AUSCANN GROUP HOLDINGS LTDAC8Pharmaceuticals, Biotechnology & Life Sciences

AC8 Company Information

Name:

AusCann Group Holdings Ltd

Sector:

Healthcare

Industry:

Drug Manufacturers—Specialty & Generic

GIC Industry:

Pharmaceuticals

GIC Sub Industry:

Pharmaceuticals

Address:

35 Havelock Street West Perth WA Australia 6005

Phone:

61 8 6305 0705

CFO & Co-Company Sec.:

Mr. Quentin Heath Megson

Chief Operating Officer:

Ms. Sheena Emslie

Chief Medical Advisor:

Dr. Marc Russo

Company Sec.:

Ms. Susan Patricia Hunter A.C.A., B.Com., BCom, F Fin, ACA, AGIA, FFin, GAIC

Company Overview:

AusCann Group Holdings Ltd, a pharmaceutical company, researches, develops, cultivates, produces, markets, and sells cannabinoids-based pharmaceuticals in Australia and internationally. It offers hard-shell capsules for the treatment for chronic pain. The company has a strategic partnership with Tasmanian Alkaloids. AusCann Group Holdings Ltd is based in West Perth, Australia.

AC8 Share Price Information

Shares Issued:

317.05M

Market Capitalisation:

$45.97M

Revenue (TTM):

$670.61K

Revenue Per Share (TTM):

$0

Earnings per Share:

$-0.025

Operating Margin (TTM):

$-9.76

Return On Assets (TTM):

$-0.10

Return On Equity (TTM):

$-0.16

Quarterly Revenue Growth (YOY):

-0.724

Gross Profit(TTM):

$670.61K

Diluted Earnings Per Share (TTM):

$-0.021

AC8 CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-7,779,549

Change To Liabilities:

$575.70K

Total Cashflow From Investing Activities:

$-7,779,549

Net Income:

$-7,649,221

Total Cash From Operating Activities:

$-4,968,377

Depreciation:

$56.24K

Other Cashflow From Investing Activities:

$-639,878

Change To Account Receivables:

$-16,537

Sale Purchase Of Stock:

$-1,726,118

Capital Expenditures:

$7.14M

AC8 Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-7,649,221

Net Income:

$-7,649,221

Gross Profit:

$670.61K

Operating Income:

$-7,167,204

Other Operating Expenses:

$2.25M

Total Revenue:

$670.61K

Total Operating Expenses:

$7.17M

AC8 Balance Sheet

Balance Sheet Date:

2019-06-30

Total Liabilities:

$1.20M

Total Stockholder Equity:

$41.67M

Other Current Liabilities:

$83.72K

Total Assets:

$42.87M

Common Stock:

$75.45M

Other Current Assets:

$169.89K

Retained Earnings:

$-35,021,228

Cash:

$35.31M

Total Current Liabilities:

$1.20M

Property - Plant & Equipment:

$7.19M

Net Tangible Assets:

$41.67M

Total Current Assets:

$35.67M

Net Receivables:

$2.64K

Short-Term Investments:

$7.19M

Accounts Payable:

$1.03M

Non Currrent Assets (Other):

$7.19M

Short-Term Investments:

$7.19

Non Current Liabilities Total:

$0

AC8 Share Price History

AC8 News

24 Apr, 2020
AusCann Group Holdings Ltd (ASX:AC8) shareholders should be happy to see the share price up 25% in the last month. But...
26 Jan, 2020
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
27 Oct, 2019
A look at the shareholders of AusCann Group Holdings Ltd (ASX:AC8) can tell us which group is most powerful...
12 Sep, 2019
It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be...